Liraglutide Treatment to Patients With Severe Renal Insufficiency

The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details. Identifier: NCT01394341
Recruitment Status : Completed
First Posted : July 14, 2011
Last Update Posted : October 9, 2013
Novo Nordisk A/S
The GCP unit at Copenhagen University Hospital
Information provided by (Responsible Party):
Bo Feldt-Rasmussen, Rigshospitalet, Denmark